中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月17日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (17): 119-122    
  妇幼医学 本期目录 | 过刊浏览 | 高级检索 |
喜炎平在急性呼吸道感染患儿中的应用效果
卢明成 秦璇 薛宏彦▲
甘肃省天水市妇幼保健院儿科
Application effect of Xiyanping in children with acute respiratory tract infection
LU Mingcheng QIN Xuan XUE Hongyan▲
Department of Pediatrics,Tianshui Maternal and Child Health Hospital
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨喜炎平在急性呼吸道感染患儿中的应用效果。方法 选取2020年2月至2021年5月天水市妇幼保健院儿科收治的96 例急性呼吸道感染患儿作为研究对象,采用随机数字表法将其分为试验组(n=48)和对照组(n=48)。试验组采用喜炎平注射液治疗,对照组采用克洛已新干混悬剂治疗。比较两组患儿的治疗效果、临床症状、炎症指标与不良反应发生率。结果 试验组患儿治疗总有效率高于对照组,差异有统计学意义(P<0.05);实验组患儿咳嗽、发热、咽喉肿痛、鼻塞、肺啰音症状的消失时间均短于对照组,差异有统计学意义(P<0.05);治疗后,试验组患儿的血清白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)水平均低于对照组,差异有统计学意义(P<0.05);两组患儿的不良反应发生率比较,差异无统计学意义(P>0.05)。结论 喜炎平注射液治疗急性呼吸道感染患儿效果显著,能快速遏制患儿咳嗽等临床症状,其作用机制可能与降低患儿体内炎症因子IL-6、IL-1β、TNF-α 水平有关。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
卢明成
秦璇
薛宏彦
关键词 喜炎平急性呼吸道感染炎症因子不良反应    
Abstract:Objective To explore the application effect of Xiyanping in children with acute respiratory tract infection.Methods From February 2020 to May 2021,96 children with acute respiratory infection admitted to the Department of Pediatrics of Tianshui Maternal and Child Health Hospital were selected as the research objects,and they were divided into the experimental group (n=48) and the control group (n=48) using the random number table method (n=48).The experimental group was treated with Xiyanping Injection,and the control group was treated with Clohexine Dry Suspension.The treatment effect,clinical symptoms,inflammatory indicators and incidence of adverse reactions between the two groups were compared.Results The total effective rate of treatment in children in the experimental group was higher than that in the control group,and the difference was statistically significant (P<0.05).The disappearance time of cough,fever,sore throat,nasal congestion,and pulmonary rales in the experimental group were shorter than those in the control group,the differences were statistically significant (P<0.05).After treatment,the levels of serum interleukin-6 (IL-6),interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) were lower than those of the control group,and the differences were statistically significant (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion Xiyanping Injection is effective in the treatment of children with acute respiratory tract infection and can quickly curb children′s cough and other clinical symptoms.The mechanism of action may be related to the reduction of inflammatory factors IL-6,IL-1β and TNF-α levels in children.
Key wordsXiyanping    Acute respiratory infection    Inflammatory factors    Adverse reaction
    
作者简介: 卢明成(1971-),男,甘肃天水人,副主任医师,研究方向:儿内科。
引用本文:   
卢明成;秦璇;薛宏彦. 喜炎平在急性呼吸道感染患儿中的应用效果[J]. 中国当代医药, 2022, 29(17): 119-122.
LU Mingcheng; QIN Xuan; XUE Hongyan. Application effect of Xiyanping in children with acute respiratory tract infection. 中国当代医药, 2022, 29(17): 119-122.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I17/119
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载